Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 2, 2008, Pages 93-104

  Hsieh, Yu Lin ^a   Chiang, Hao ^a   Tseng, To Jung ^a   Hsieh, Sung Tsang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

4 methylcatechol; Calcitonin geneyrelated peptide; Capsaicin; Nerve regeneration; Neuropathy; Resiniferatoxin; Skin denervation; Substance P

Indexed keywords

4 METHYLCATECHOL; 4-METHYLCATECHOL; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CATECHOL DERIVATIVE; DITERPENE; NEUROPROTECTIVE AGENT; PGP9.5 PROTEIN, MOUSE; RESINIFERATOXIN; SUBSTANCE P; UBIQUITIN THIOLESTERASE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; DRUG INTERACTION; HYPERALGESIA; INNERVATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; NERVE CONDUCTION; NERVE REGENERATION; NONMYELINATED NERVE; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHYSIOLOGY; REACTION TIME; SKIN; SPINAL GANGLION; ULTRASTRUCTURE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CATECHOLS; DISEASE MODELS, ANIMAL; DITERPENES; DRUG INTERACTIONS; GANGLIA, SPINAL; HYPERALGESIA; MALE; MICE; MICE, INBRED ICR; NERVE FIBERS, UNMYELINATED; NERVE REGENERATION; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PERIPHERAL NERVOUS SYSTEM DISEASES; REACTION TIME; SKIN; SUBSTANCE P; UBIQUITIN THIOLESTERASE;

EID: 42949122538     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/nen.0b013e3181630bb8     Document Type: Article

References (51)

1. Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: Correlations with diabetic duration and functional impairments. Brain 2004;127:1593-1605
2. Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: Studies in normal controls and in people with diabetes, with and without neuropathy. Brain 2004;127:1606-15 (Pubitemid 38899413)
3. Holland NR, Crawford TO, Hauer P, Cornblath DR, Griffin JW, McArthur JC. Small-fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases. Ann Neurol 1998;44:47-59 (Pubitemid 28323654)
4. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Ann Neurol 1994;35:304-11 (Pubitemid 24089653)
5. Verdu E, Vilches JJ, Rodriguez FJ, Ceballos D, Valero A, Navarro X. Physiological and immunohistochemical characterization of cisplatininduced neuropathy in mice. Muscle Nerve 1999;22:329-40 (Pubitemid 29116186)
6. Hsieh ST, Chiang HY, Lin WM. Pathology of nerve terminal degeneration in the skin. J Neuropathol Exp Neurol 2000;59:297-307
7. Tseng TJ, Chen CC, Hsieh YL, Hsieh ST. Effects of decompression on neuropathic pain behaviors and skin reinnervation in chronic constriction injury. Exp Neurol 2007;204:574-82
8. Raisinghani M, Pabbidi RM, Premkumar LS. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin. J Physiol (Lond) 2005;567:771-86 (Pubitemid 41387825)
9. Neubert JK, Karai L, Jun. JH, Kim HS, Olah Z, Iadarola MJ. Peripherally induced resiniferatoxin analgesia. Pain 2003;104:219-28 (Pubitemid 36835891)
10. Almasi R, Petho G, Bolcskei K, Szolcsanyi J. Effect of resiniferatoxin on the noxious heat threshold temperature in the rat: A novel heat allodynia model sensitive to analgesics. Br J Pharmacol 2003;139:49-58 (Pubitemid 36645307)
11. Karai L, Brown DC, Mannes AJ, et al. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 2004;113:1344-52 (Pubitemid 39069933)
12. Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 2005;65:400-5 (Pubitemid 40248050)
13. Helyes Z, Szabo A, Nemeth J, et al. Antiinflammatory and analgesic effects of somatostatin released from capsaicin-sensitive sensory nerve terminals in a Freund's adjuvant-induced chronic arthritis model in the rat. Arthritis Rheum 2004;50:1677-85 (Pubitemid 38608091)
14. Kennedy WR, Wendelschafer-Crabb G. Utility of the skin biopsy method in studies of diabetic neuropathy. Electroencephalogr Clin Neurophysiol 1999;50:553-59
15. Kennedy WR, Wendelschafer-Crabb G. Utility of the skin biopsy method in studies of diabetic neuropathy. Electroencephalogr Clin Neurophysiol 1999;50:553-59
16. Kennedy WR. Opportunities afforded by the study of unmyelinated nerves in skin and other organs. Muscle Nerve 2004;29:756-67 (Pubitemid 38720812)
17. Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation. Pain 1999;81:135-45 (Pubitemid 29199909)
18. Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: Correlation with sensory function. J Neurosci 1998;18:8947-59 (Pubitemid 28491759)
19. Luo W, Wickramasinghe SR, Savitt JM, Griffin JW, Dawson TM, Ginty DD. A hierarchical NGF signaling cascade controls Ret-dependent and Ret-independent events during development of nonpeptidergic DRG neurons. Neuron 2007;54:739-54 (Pubitemid 46843519)
20. Ehlers MD. Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system. Nat Neurosci 2003;6:231-42 (Pubitemid 36278281)
21. Snider WD. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994;77:627-38 (Pubitemid 24175600)
22. Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. JAMA 2000;284:2215-21
23. Perez-Perez M, Garcia-Suarez O, Esteban I, et al. p75NTR in the spleen: Age-dependent changes, effect of NGF and 4-methylcatechol treatment, and structural changes in p75NTR-deficient mice. Anat Rec A Discov Mol Cell Evol Biol 2003;270A:117-28 (Pubitemid 37238369)
24. Kimura N, Nishizaki K, Orita Y, Masuda Y. 4-Methylcatechol, a potent inducer of nerve growth factor synthesis, protects spiral ganglion neurons from aminoglycoside ototoxicity-Preliminary report. Acta Otolaryngol Suppl 1999;540:12-15 (Pubitemid 29336465)
25. Kaechi K, Ikegami R, Nakamura N, Nakajima M, Furukawa Y, Furukawa S. 4-Methylcatechol, an inducer of nerve growth factor synthesis, enhances peripheral nerve regeneration across nerve gaps. J Pharmacol Exp Ther 1995;272:1300-4
26. Pan HL, Khan GM, Alloway KD, Chen SR. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: Mechanism of action. J Neuros ci 2003;23:2911-19 (Pubitemid 36418627)
27. Lin WM, Hsieh ST, Huang IT, Griffin JW, Chen WP. Ultrastructural localization and regulation of protein gene product 9.5. Neuroreport 1997;8:2999-3004 (Pubitemid 27421722)
28. Ko MH, Chen WP, Hsieh ST. Neuropathology of skin denervation in acrylamide-induced neuropathy. Neurobiol Dis 2002;11:155-65
29. Chiang HY, Chien HF, Shen HH, et al. Reinnervation of muscular targets by nerve regeneration through guidance conduits. J Neuropathol Exp Neurol 2005;64:576-87
30. Mogil JS, Wilson SG, Bon K, et al. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999;80:67-82 (Pubitemid 29151691)
31. Cliffer KD, Siuciak JA, Carson SR, et al. Physiological characterization of taxol-induced large-fiber sensory neuropathy in the rat. Ann Neurol 1998;43:46-55 (Pubitemid 28124648)
32. Lipton RB, Apfel SC, Dutcher JP, et al. Taxol produces a predominantly sensory neuropathy. Neurology 1989;39:368-73 (Pubitemid 19094727)
33. Jeftinija S, Liu F, Jeftinija K, Urban L. Effect of capsaicin and resiniferatoxin on peptidergic neurons in cultured dorsal root ganglion. Regul Pept 1992;39:123-35
34. Caudle RM, Karai L, Mena N, et al. Resiniferatoxin-induced loss of plasma membrane in vanilloid receptor expressing cells. Neurotoxicology 2003;24:895-908 (Pubitemid 37486265)
35. Acs G, Biro T, Acs P, Modarres S, Blumberg PM. Differential activation and desensitization of sensory neurons by resiniferatoxin. J Neurosci 1997;17:5622-28 (Pubitemid 27300326)
36. Athanasiou A, Smith PA, Vakilpour S, et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: How vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 2007;354:50-55 (Pubitemid 46123197)
37. Kennedy WR, Said G. Sensory nerves in skin: Answers about painful feet? Neurology 1999;53:1614-15 (Pubitemid 29530326)
38. Hahn K, Triolo A, Hauer P, McArthur JC, Polydefkis M. Impaired reinnervation in HIV infection following experimental denervation. Neurology 2007;68:1251-56 (Pubitemid 46625969)
39. Sommer C, Lauria G. Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 2007;6:632-42 (Pubitemid 46921057)
40. Lauria G, Lombardi R. Skin biopsy: A new tool for diagnosing peripheral neuropathy. BMJ 2007;334:1159-62 (Pubitemid 46910023)
41. Pleasure DE. Dwindling indications for sural nerve biopsy. Arch Neurol 2007;64:935-36 (Pubitemid 47047991)
42. Olah Z, Szabo T, Karai L, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 2001;276:11021-30 (Pubitemid 38089283)
43. Grant ER, Dubin AE, Zhang SP, Zivin RA, Zhong Z. Simultaneous intracellular calcium and sodium flux imaging in human vanilloid receptor 1 (VR1) Ytransfected human embryonic kidney cells: A method to resolve ionic dependence of VR1-mediated cell death. J Pharmacol Exp Ther 2002;300:9-17 (Pubitemid 34028502)
44. Kim SR, Lee DY, Chung ES, Oh UT, Kim SU, Jin BK. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J Neurosci 2005;25:662-71
45. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 1995;15:6445-52
46. Han P, McDonald HA, Bianchi BR, et al. Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes. Biochem Pharmacol 2007;73:1635-45 (Pubitemid 46527537)
47. Callizot N, Warter JM, Poindron P. Pyridoxine-induced neuropathy in rats: A sensory neuropathy that responds to 4-methylcatechol. Neurobiol Dis 2001;8:626-35 (Pubitemid 32758666)
48. Pezet S, McMahon SB. Neurotrophins: Mediators and modulators of pain. Annu Rev Neurosci 2006;29:507-38 (Pubitemid 44476854)
49. Bloch J, Fine EG, Bouche N, Zurn AD, Aebischer P. Nerve growth factor-and neurotrophin-3Yreleasing guidance channels promote regeneration of the transected rat dorsal root. Exp Neurol 2001;172:425-32 (Pubitemid 34075091)
50. Lin B, Pirrung MC, Deng L, Li Z, Liu Y, Webster NJG. Neuroprotection by small molecule activators of the nerve growth factor receptor. J Pharmacol Exp Ther 2007;322:59-69 (Pubitemid 46956348)
51. Sometani A, Nomoto H, Nitta A, Furukawa Y, Furukawa S. 4-Methylcatechol stimulates phosphorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons. J Neurosci Res 2002;70:335-39 (Pubitemid 35222369)